But like any possibly weak trigger, sweeteners may play only a partial role in migraine symptoms
Ambery PD, Klammt S, Posch MG et al (2018) MEDI0382, a GLP-1/glucagon receptor dual agonist, meets safety and tolerability endpoints in a single-dose, healthy-subjects, randomized, phase 1 study
Downregulation of ghrelin production in the stomach and neuropeptide Y (NPY) in the hypothalamus is associated with the appetite reduction effects of C
This is another piece of great news for our patients living with diabetes, said Lawrence Leiter, an endocrinologist at St
When a single session included both liver and spleen acquisitions, these were recorded as separate rows
Nobody meets her and thinks shes a psycho